Pier Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.09M Buy
+69,240
New +$3.93M 0.45% 93

Other funds holding IONS

Pier Capital's IONS Position: Q3 2026 in Review

Pier Capital opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2026: 69,240 shares worth $3.09M. The stake represents 0.45% of the portfolio and ranks #93 among its holdings.

464 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Pier Capital held 69,240 shares of Ionis Pharmaceuticals worth $3.09M as of Q3 2026.
  • Ionis Pharmaceuticals was a new Pier Capital position in Q3 2026.
  • Ionis Pharmaceuticals made up 0.45% of Pier Capital's portfolio in Q3 2026, its #93 holding.
  • 464 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Pier Capital's 13F filing for Q3 2026, filed 13 Nov 2026.